
Innovative solutions are making personalized cell and gene therapies accessible to all.
Innovative solutions are making personalized cell and gene therapies accessible to all.
Stable cell line development can benefit from applying integrated analytical technologies.
Bringing promising ADC candidates to market faster hinges on the biopharma industry investing in linker design capabilities.
Emerging therapies, such as cell and gene therapies, come with unique challenges that must be planned for in advance.
The latest developments in emerging therapies, including new innovations and collaborative efforts in manufacturing.